Skip to content

Clinical trials

Terminated Lymphoma, Large B-Cell, Diffuse trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Terminated Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20111
20121
20151
20162
20171
20181
20191
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AbbVie1
Atara Biotherapeutics1
Baxalta now part of Shire1
BeOne Medicines1
Bristol-Myers Squibb1
Celgene Corporation1
Genmab1
GlaxoSmithKline1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Follicular8
Lymphoma, Non-Hodgkin8
Lymphoma, Mantle-Cell5
Lymphoma, B-Cell, Marginal Zone4
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Acute3
Burkitt Lymphoma2
Hodgkin Disease2
Lymphoma2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.